A modelling study shows that lenacapavir could end Aids in South Africa by 2032 – but only if between two and four million ...

The Xpert MTB/Ultra molecular diagnostic test may become a viable option for detecting tuberculosis (TB) in the stool of ...

各位亲爱的股东，大家早上好中午好晚上好。据外媒报道，罗氏美国基因治疗公司Spark Therapeutics在美国费城裁员337人。裁员人数超过公司现有员工的一半，剩余310人将整合进入罗氏。也就是说，Spark Therapeutics可能将不复存在了。另外，罗氏在Santa Clara的Molecular ...

Human immunodeficiency virus, if untreated, causes acquired immunodeficiency syndrome (AIDS), and death. HIV is almost entirely preventable by using condoms, or by taking PrEP drugs. PrEP drugs do not ...

2025 年 1 月，葛兰素史克的卡替拉韦注射液 (艾普特)正式在国内上市，这是国内首个且唯一获批用于 HIV 暴露前预防的长效注射针剂。它属于 HIV - 1 整合酶链转移抑制剂，通过阻止病毒 DNA 整合到人类免疫细胞，抑制 HIV ...

While Gilead is eliminating 149 positions at its headquarters in Foster City, Roche is letting go of 108 workers at its ...

The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...

CDC layoffs and program cuts gutted branches responsible for a slew of HIV prevention services, imperiling decades of ...

Scientists from the University of KwaZulu-Natal conducted a test trial on a group of women from Umlazi to determine the ...

A NEW injection that could prevent HIV infection has successfully completed an early safety trial, according to a report in The Lancet medical journal. The injection, known as Lenacapavir, works by ...

Is long-acting HIV treatment as effective as daily pills? Early results say yes—with some risks of resistance in rare cases.